Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Rhabdoid Tumor (MRT)”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02114229
What this trial is testing

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Who this might be right for
Malignant Rhabdoid TumorAtypical Teratoid Rhabdoid Tumor
St. Jude Children's Research Hospital 125
Not applicableWithdrawnNCT01453465
What this trial is testing

Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorRhabdoid Tumor of the Kidney
Children's Oncology Group
Early research (Phase 1)Ended earlyNCT01747876
What this trial is testing

Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma

Who this might be right for
Malignant Rhabdoid Tumors (MRT)Neuroblastoma
Novartis Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT02601950
What this trial is testing

Tazemetostat in Adult Participants With Soft Tissue Sarcoma

Who this might be right for
Malignant Rhabdoid Tumors (MRT)Rhabdoid Tumors of the Kidney (RTK)Atypical Teratoid Rhabdoid Tumors (ATRT)+8 more
Epizyme, Inc. 267
Testing effectiveness (Phase 2)Ended earlyNCT04897880
What this trial is testing

Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT

Who this might be right for
Rhabdoid TumorAtypical Teratoid/Rhabdoid TumorMalignant Rhabdoid Tumor+1 more
Australian & New Zealand Children's Haematology/Oncology Group 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05407441
What this trial is testing

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors

Who this might be right for
Atypical Teratoid Rhabdoid TumorINI1 (SMARCB1)-Deficient Primary CNS Malignant TumorsSMARCA4-deficient Primary CNS Malignant Tumors+4 more
Susan Chi, MD 49